REFERÊNCIAS:
1. Alcon data on file, 2022. REF-20875.
2. Bickle K, Miller JR, Tauber J, et al. Multi symptom Relief with Propylene Glycol Hydroxypropyl Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post Marketing Prospective Study. Opthalmol Ther. 2024; 13(2): 481 494.
3. Silverstein S, Yeu E, Tauber J, Guillon M, Jones L, Galarreta D, Srinivasan S, Manoj V. Symptom Relief Following a Single Dose of Propylene Glycol Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167 3177.
4. Srinivasan S, Williams R. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease. Clin Ophthalmol. 2022;16:3311-3326.
5. Springs CL. Novel hydroxypropyl guar gellable lubricant eye drops for treatment of dry eye. Ad Ther. 2010 Oct;27(10):681 90. doi: 10.1007/s12325 010 0052 3. Epub 2010 Aug 26.
6. Based on internal analysis by Alcon using data from the following source: IQVIA Consumer Health Insights, US Dollar Mnf Market Share, for the period MAT 09/2023 reflecting estimates of real world activity. Copyright IQVIA. All rights reserved.
7. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.
8. Christensen MT, Martin AE, Bloomenstein M. A comparison of efficacy between Systane Ultra and Optive lubricant eye drops when tested with dry eye patients. Optometry. 2009;80(6):315.
9. Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a hyaluronic acid/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497.
10. Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278.
O uso do dispositivo médico pode trazer riscos. Leia sempre as Instruções de Uso para informações sobre indicações, contraindicações e advertências. Consulte seu oftalmologista para eventuais esclarecimentos ou dúvidas.
Registro Anvisa: Systane Complete Sem Conservantes: n° 81869420139, Systane Hidratação: n° 81869420140, Systane Ultra: n° 81869420137, Systane UL: n° 81869420148.